DARPA research project
Ended Definitive Contract Awarded Last action
- Contract number
- HR001119C0069
- Awardee
-
J. Craig Venter Institute, Inc. UEI FL8UNYTG72D1
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $320,207
Award facts
- Opportunity
-
- HR001118S0041 Solicitation number
- Biological Technologies Award Notice · Posted Apr 25, 2018
- Contract value 27% obligated
-
- $669,546.00 Current, with exercised options
- $1,181,897.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 138 offers Basic Research
- Pricing
- Cost No Fee
- Place of performance
- La Jolla, CA 92037, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | -$349,339 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $349,339 | |
| Other Administrative Action | $0 | |
| Original award | $320,207 |
About this award
J. Craig Venter Institute, Inc. (JCVI) was awarded a $1.18 million definitive contract by the Defense Advanced Research Projects Agency (DARPA) for Task 5 of a research project, with performance in La Jolla, California. The contract, awarded on April 5, 2019, operates under a cost-no-fee pricing structure with an ultimate completion date of December 31, 2020. No small business set-aside was applied to this award. As a non-profit genomics research organization, JCVI brings specialized expertise in synthetic biology, genomics, bioinformatics, and infectious disease research to support DARPA's advanced research objectives.
JCVI established a subcontract with Mriglobal (Midwest Research Institute) on June 20, 2019, to characterize an ethylene gas whole body exposure system for use with animals to determine epigenetic markers following ethylene gas exposure. Mriglobal, a Kansas City-based 501(c)(3) research organization, brings substantial capabilities in laboratory testing and scientific research infrastructure to this effort. The collaboration between JCVI's genomics and synthetic biology expertise and Mriglobal's advanced laboratory facilities and animal model development capabilities positions the contract to deliver sophisticated research support aligned with DARPA's mission to advance defense-related scientific innovation.
Quick answers
Who was awarded contract HR001119C0069?
HR001119C0069 was awarded to J. Craig Venter Institute, Inc. by Defense Advanced Research Projects Agency (Department of Defense) on April 5, 2019.
How much is contract HR001119C0069 worth?
The government has obligated $320,207 on HR001119C0069. Its current value, with exercised options, is $669,546. Its potential value, with all options, is $1,181,897.
Was contract HR001119C0069 competed?
The extent of competition for HR001119C0069 was full and open competition. The government received 138 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award